-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: BIOtechNOW Editor
Pharma & Biotech Companies Donate Hundreds of Millions of Dollars to Copayment Foundations. Here’s Why.
In addition to using their own Patient Assistance Programs, many pharma and biotech companies are supporting independent 501(c)3 non-profit copayment foundations to increase treatment compliance, access to care for insured Americans (including Medicare patients), and to promote proper disease management. Copayment foundations have helped hundreds of thousands of insured Americans afford their coverage and their treatments. The HealthWell Foundation, one of the nation’s largest non-profits, recently issued a white paper on copayment assistance as a Read More >
What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?
The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more than 650,000 direct jobs (supporting a total of nearly 4 million jobs) and an economic output that totals more than $900 billion.[i] This significant economic impact is due to the high value-added nature of the sector, its extensive supply chain relationships, and high-wage jobs. As a result, gains and losses in the biopharmaceutical sector cascade across many important economic sectors Read More >
Creating a Preparedness Plan: A Good Investment
No one thinks that their company may be affected by a flood, earthquake or other disaster, but with 43 natural disasters in 2011 (Emergency Events Database search on 2011 US based disasters. http://www.emdat.be/advanced-search. Accessed September 15, 2012.) directly affecting millions in the United States, and projections for more for the next few years, more and more small businesses are being seriously impacted. While many small biotech company owners think disruptions won’t happen to their business, Read More >
Childhood Cancer Groups Join Forces to Train Childhood Cancer Leaders
Cancer remains the leading cause of death by disease for children in the United States today. Each year, about 13,500 children are diagnosed with cancer—more than a schoolroom of children every day. September is National Childhood Cancer Awareness Month in the U.S., and our organizations are drawing attention to these devastating diseases by training advocates to take action to change the future for children with cancer. While the five-year survival rates of some childhood cancers have improved, Read More >
The Importance of Encouraging Adult Vaccination This Fall
As National Immunization Awareness Month ends and flu season approaches, many adults around the country are making plans to get their annual influenza vaccine. In recent years, awareness of the need for influenza vaccination among adults has increased, however, immunization rates among US adults to prevent other vaccine-preventable diseases (VPDs) is still well below current public health goals. While getting an influenza vaccine is a great first step, we still have a long way to Read More >
